
|Poll|February 8, 2022
POLL: Which AD comorbidities were most interesting?
Author(s)Dermatology Times Staff
Click to answer this week's poll on the newly released AAD guidelines on AD comorbidites.
Advertisement
The AAD has recently released guidlines on AD and its association with other conditions. Which section was more intriguing to you?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
AI Analysis Reveals Menopausal Hair Loss Linked to Systemic Health and Inflammation
3
Dual-Action Microneedle Patch Shows Promise for Psoriasis in Preclinical Study
4
Novel Botanical Moisturizer Demonstrates Superior Efficacy Over Metronidazole in Phase 2 Rosacea Trial
5














